Bevacizumab and Retinal Vascular Occlusions
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2006 by Asociación para Evitar la Ceguera en México.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Asociación para Evitar la Ceguera en México
Information provided by:
Asociación para Evitar la Ceguera en México
ClinicalTrials.gov Identifier:
NCT00347711
First received: June 30, 2006
Last updated: July 3, 2006
Last verified: June 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.
| Condition | Intervention | Phase |
|---|---|---|
|
Edema Macular Vascular Occlusion |
Drug: Intravitreal injection |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label |
Resource links provided by NLM:
Genetics Home Reference related topics:
age-related macular degeneration
X-linked juvenile retinoschisis
MedlinePlus related topics:
Edema
U.S. FDA Resources
Further study details as provided by Asociación para Evitar la Ceguera en México:
Eligibility| Ages Eligible for Study: | 40 Years to 90 Years |
| Genders Eligible for Study: | Both |
Criteria
Inclusion Criteria:
- Vascular occlusion and edema macular diagnosticated by fluorescein angiography and coherent optic tomography
Exclusion Criteria:
- Previous surgery
- Uveitis
- Glaucoma
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00347711
Locations
| Mexico | |
| Asociacion para Evitar la Ceguera en Mexico | Recruiting |
| Mexico, D.F. Mexico, Mexico, 04030 | |
| Contact: Griselda Alvarez, Fellow 5255 10841400 ext 1171 retinamex@yahoo.com. | |
Sponsors and Collaborators
Asociación para Evitar la Ceguera en México
Investigators
| Principal Investigator: | Griselda Alvarez, Fellow | APEC |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00347711 History of Changes |
| Other Study ID Numbers: | APEC-0020 |
| Study First Received: | June 30, 2006 |
| Last Updated: | July 3, 2006 |
| Health Authority: | Mexico: Secretaria de Salud |
Additional relevant MeSH terms:
|
Edema Macular Edema Signs and Symptoms Macular Degeneration |
Retinal Degeneration Retinal Diseases Eye Diseases |
ClinicalTrials.gov processed this record on May 23, 2013